TORL Biotherapeutics
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers.
TORL Biotherapeutics Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Culver City, California, USA
